Affiliations

Throughout our pursuit of Novel Chemical Entities (NCEs) based on the MDXX class of molecules, we found a global shortage of clinical-grade MDMA drug products. PharmAla believes that researchers and clinicians need access to the highest-quality supply of clinical-grade Active Pharmaceutical Ingredients (APIs) to innovate. PharmAla proudly supplies dozens of institutions and organizations dedicated to the medical use of MDMA to treat a wide range of disorders and indications.